CAMT CAMTEK LTD
Optical Instruments & Lenses · Nasdaq · SEC CIK 1109138 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY15.6%
TTM net income YoY-57.2%
TTM EPS YoY-57.0%
Revenue 3-yr CAGR15.6%
Net income 3-yr CAGR-14.1%
Margins
Gross margin50.5%
Operating margin25.8%
Net margin10.2%
FCF margin25.7%
EBITDA margin28.2%
Returns
ROE8.7%
ROA4.7%
ROIC (approx.)28.8%
Asset turnover0.46x
Leverage & solvency
Liabilities / assets51.0%
Debt / equity0.00x
Current ratio8.35x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.80x
Accruals ratio-8.5%
Payout ratio—
Capex / revenue2.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 · USD | FY20242024-12-31 · USD | FY20232023-12-31 · USD | FY20222022-12-31 · USD | FY20212021-12-31 · USD |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $496.07M | $429.23M | $315.38M | $320.91M | $269.66M |
| Cost of revenue | $245.75M | $219.28M | $167.74M | $161.05M | $132.31M |
| Gross profit | $250.32M | $209.95M | $147.63M | $159.86M | $137.34M |
| R&D expense | $48.34M | $38.29M | $31.47M | $28.86M | $23.47M |
| SG&A expense | $73.77M | $63.59M | $50.75M | $49.50M | $42.97M |
| Operating income | $128.20M | $108.07M | $65.41M | $81.50M | $70.90M |
| Pretax income | $52.34M | $131.24M | $87.63M | $88.19M | $71.93M |
| Income tax | $1.61M | $12.72M | $9.00M | $8.24M | $11.65M |
| Net income | $50.72M | $118.52M | $78.63M | $79.95M | $60.28M |
| EBITDA | $139.98M | $118.73M | $71.20M | $85.59M | $73.71M |
| EPS (basic) | 1.11 | 2.62 | 1.76 | 1.81 | 1.38 |
| EPS (diluted) | 1.04 | 2.42 | 1.63 | 1.68 | 1.34 |
| Dividends declared per share | — | 1.33ILS | — | — | — |
| Weighted avg. shares (diluted) | 49,970 | 49,369 | 48,863 | 48,229 | 45,035 |
| Banking | |||||
| Provision for credit losses | $11,000 | $34,000 | $100,000 | $0 | $0 |
| Balance sheet | |||||
| Cash & equivalents | $177.85M | $126.22M | $119.97M | $148.16M | $241.94M |
| Short-term investments | $78.86M | $30.81M | $18.82M | $0 | — |
| Receivables | $90.83M | $99.47M | $87.30M | $80.61M | $57.83M |
| Inventory | $112.20M | $111.20M | $85.91M | $65.54M | $58.76M |
| Current assets | $897.00M | $620.06M | $546.79M | $556.96M | $520.18M |
| PP&E, net | $65.11M | $54.20M | $41.99M | $33.14M | $25.40M |
| Goodwill | $74.34M | $74.34M | $74.34M | $0 | — |
| Intangibles | $10.06M | $13.36M | $16.94M | $597,000 | $610,000 |
| Total assets | $1.26B | $892.04M | $787.67M | $677.09M | $583.76M |
| Current liabilities | $107.42M | $123.91M | $96.67M | $88.50M | $89.69M |
| Total liabilities | $642.83M | $342.81M | $311.52M | $292.99M | $290.13M |
| Shareholders' equity | $617.00M | $549.24M | $476.15M | $384.10M | $293.63M |
| Shares outstanding | 45.83M | 45.45M | 44.90M | 44.41M | 43.85M |
| Cash flow statement | |||||
| Operating cash flow | $141.87M | $122.24M | $79.32M | $57.80M | $60.96M |
| Capital expenditure | $14.40M | $10.10M | $8.10M | $8.20M | $4.07M |
| Free cash flow | $127.47M | $112.14M | $71.23M | $49.60M | $56.89M |
| Investing cash flow | -$310.32M | -$55.91M | -$107.45M | -$150.79M | -$120.18M |
| Financing cash flow | $218.99M | -$60.05M | $182,000 | $3,000 | $194.80M |
| Depreciation & amortization | $11.78M | $10.67M | $5.78M | $4.09M | $2.81M |
| Stock-based compensation | $16.89M | $14.50M | $12.60M | $10.52M | $5.82M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· This company uses different currencies across periods or line items (e.g. USD convenience translations in annual reports). Each column header shows its currency and cells in a different currency are marked; do not compare figures across currencies. Charts use only periods in the latest period's currency.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.